Alpine Immune Sciences (ALPN) Investor Presentation - Slideshow

Leading the Next Evolution of Immunotherapies March 2023 Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section27A of the Securities Act of 1933, Section21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based onhistorical fact and include statements regarding Alpine’s platform technology, potential therapies, potential milestone and royalty payments, futuredevel ...